Findlay D, Lawrence J R
Eur J Clin Pharmacol. 1978 Dec 1;14(4):231-5. doi: 10.1007/BF00560455.
An established method for collecting uncontaminated parotid saliva has been applied to assessment of salivary flow rate. Following single doses of 0.3 mg clonidine and 1.0 mg tiamenidine (HOE 440) changes in blood pressure, heart rate, sedation (assessed by a self-rating scale) and salivary flow were followed in nine normal subjects. Both drugs produced a fall in systolic and diastolic blood pressure, sedation, depression of salivary flow and a lowering of heart rate. These changes were maximal between 2 and 6 h and were more marked after clonidine than after tiamenidine. As tiamenidine 1.0 mg did not produce a hypotensive effect equivalent to clonidine 0.3 mg direct comparison of side-effects attributable to these agents proved difficult. The evidence suggests, however, that tiamenidine would cause sedation and reduction in salivary flow comparable to clonidine if given in an equivalent hypotensive dose.
一种已确立的收集未受污染腮腺唾液的方法已应用于唾液流速评估。在9名正常受试者中,给予单次剂量的0.3毫克可乐定和1.0毫克噻美尼定(HOE 440)后,跟踪血压、心率、镇静程度(通过自评量表评估)和唾液流速的变化。两种药物均导致收缩压和舒张压下降、镇静、唾液流速降低以及心率下降。这些变化在2至6小时之间最大,且可乐定后的变化比噻美尼定后更明显。由于1.0毫克噻美尼定未产生与0.3毫克可乐定相当的降压效果,因此难以直接比较这些药物的副作用。然而,有证据表明,如果给予等效的降压剂量,噻美尼定将导致与可乐定相当的镇静和唾液流速降低。